Ebola vaccine trial suspended after side effects
LONDON, England - Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects.
In a statement issued on Thursday, the Hopitaux Universitaires de Geneve said the trial had been suspended "as a precautionary measure." The study involving 59 people began in November.
Researchers reported four cases of mild joint pain in the hands and feet in people who got the shot 10 to 15 days earlier. Officials will stop giving the vaccine next week to get more data and liaise with others who are testing the vaccine in the U.S., Canada, Germany and Gabon.
The vaccine was developed by the Canadian government and is licensed to two U.S. companies, NewLink and Merck
The trial is scheduled to resume in January in Geneva.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Lawmakers prepare for third special session this year
One dead, another injured after South 15 Street shooting
Parkview Baptist teen preps for national rodeo
Dangerous hole in Zachary neighborhood posing serious threat, residents concerned
Power restored after storms pound East Baton Rouge again Friday
Temeka Johnson basketball camp about more than the game
Saints looking to fill backfield void during Ingram's 4-game absence
Saints RB Mark Ingram says he's 'not angry' with his contract
Sean Payton's coaching style propels him into 13th year with Saints
New coach excited to change basketball culture at Southern